Lessons learned from excess mortality associated with Klebsiella pneumoniae carbapenemase 2-producing K. pneumoniae in liver transplant recipients

MeSH terms

• Adult
• Anti-Bacterial Agents / therapeutic use
• Bacterial Proteins / metabolism*
• Cross Infection / diagnosis
• Cross Infection / drug therapy
• Cross Infection / microbiology*
• Cross Infection / mortality*
• Disease Outbreaks*
• Drug Resistance, Bacterial
• Female
• Germany
• Hospitals, University
• Humans
• Kaplan-Meier Estimate
• Klebsiella Infections / diagnosis
• Klebsiella Infections / drug therapy
• Klebsiella Infections / microbiology*
• Klebsiella Infections / mortality*
• Klebsiella pneumoniae / drug effects
• Klebsiella pneumoniae / enzymology*
• Liver Transplantation / adverse effects
• Liver Transplantation / mortality*
• Male
• Microbial Sensitivity Tests
• Middle Aged
• Patient Selection
• Retrospective Studies
• Risk Factors
• Time Factors
• Treatment Outcome
• beta-Lactamases / metabolism*